109 related articles for article (PubMed ID: 7041495)
1. Studies on the fibrinolytic effect of ocrase.
Klöcking HP; Markwardt F; Hentschel H
Acta Biol Med Ger; 1981; 40(9):1161-6. PubMed ID: 7041495
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinolytic properties of a heparin-ocrase complex].
Kudrjashov BA; Liapina LA; Klöcking HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(4):573-82. PubMed ID: 64397
[TBL] [Abstract][Full Text] [Related]
3. [Animal experimental studies on the thrombolytic effect of ocrase].
Markwardt F; Klöcking HP; Sedlarik K; Drawert J
Acta Biol Med Ger; 1977; 36(9):1315-27. PubMed ID: 614755
[TBL] [Abstract][Full Text] [Related]
4. [Proteolytic enzymes produced by Aspergillus ochraceus in relation to their plasma coagulating and fibrinolytic activities].
Klechkovskaia VV; Otroshko TA; Egorov NS
Mikrobiologiia; 1979; 48(5):820-5. PubMed ID: 41165
[TBL] [Abstract][Full Text] [Related]
5. The use of proteases as thrombolytic agents from the toxicological point of view.
Klöcking HP; Sedlarik K; Hentschel H
Pol J Pharmacol Pharm; 1980; 32(2):231-5. PubMed ID: 7005879
[TBL] [Abstract][Full Text] [Related]
6. [Animal experiments on the pharmacokinetics of ocrase (author's transl)].
Markwardt F; Klöcking HP; Senf L; Schmidt HE; Drawert J; Herzmann H
Pharmazie; 1979 Dec; 34(12):827-9. PubMed ID: 397495
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinolytic activity of a protease isolated from Aspergillus ochraceus].
Klöcking HP; Markwardt F
Acta Biol Med Ger; 1971; 26(1):35-44. PubMed ID: 5103710
[No Abstract] [Full Text] [Related]
8. [Plasma-coagulating and fibrinolytic activities of fungi in the genus Aspergillus].
Klechkovskaia VV; Egorov NS
Mikrobiologiia; 1983; 52(3):396-403. PubMed ID: 6353181
[TBL] [Abstract][Full Text] [Related]
9. [Production and characterization of a soluble ocrase-polyacrylamide preparation (author's transl)].
Maksimenko AV; Walsmann P
Pharmazie; 1981; 36(2):117-9. PubMed ID: 7015368
[TBL] [Abstract][Full Text] [Related]
10. [Proteolytic system of Aspergillus ochraceus studied in relation to its plasma-coagulating and fibrinolytic activities].
Otroshko TA; Klechkovskaia BV; Egorov NS
Mikrobiologiia; 1979; 48(4):645-52. PubMed ID: 481278
[TBL] [Abstract][Full Text] [Related]
11. [Thrombolytic action of a heparin-ocrase complex].
Liapina LA; Klöcking HP
Farmakol Toksikol; 1978; 41(2):174-7. PubMed ID: 658360
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the component constitution and substrate specificity of a fibrinolytic preparation from the fungus Flammulina velutipes].
Morozova EN; Falina NN; Denisova NP; Barkova LV; Psurtseva NV
Biokhimiia; 1982 Jul; 47(7):1181-5. PubMed ID: 7052148
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
van Giezen JJ; Chung-A-Hing JE; Vegter CB; Bouma BN; Jansen JW
Thromb Haemost; 1994 Dec; 72(6):887-92. PubMed ID: 7740459
[TBL] [Abstract][Full Text] [Related]
14. [Lysis of experimentally produced arterial thrombi by means of local application of ocrase in the dog].
Sedlarik K; Perlewitz J; Klöcking HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(1):117-22. PubMed ID: 58810
[No Abstract] [Full Text] [Related]
15. Substrate and inhibitor specificity of a transient, soluble proteolytic activity from sheep rumen.
Baintner K; Szabó GC; Asbóth B
Acta Vet Hung; 1984; 32(1-2):87-90. PubMed ID: 6241989
[No Abstract] [Full Text] [Related]
16. [Effect of antibiotics and antiseptics on the fibrinolytic activity of proteases].
Chepcheruk GS; Kostiuchenko AL; Radaev AA
Vestn Khir Im I I Grek; 1980 Jun; 124(6):79-82. PubMed ID: 6998084
[TBL] [Abstract][Full Text] [Related]
17. Intraspecies differences in hemostatic venom activities of the South American rattlesnakes, Crotalus durissus cumanensis, as revealed by a range of protease inhibitors.
Salazar AM; Aguilar I; Guerrero B; Girón ME; Lucena S; Sánchez EE; Rodríguez-Acosta A
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):525-30. PubMed ID: 18685436
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB; Panchenko NI
East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological and clinical study of the thrombolytic effectiveness of ocrase].
Klöking K; Vogel H
Kardiologiia; 1981 Aug; 21(8):36-8. PubMed ID: 7026868
[No Abstract] [Full Text] [Related]
20. Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase B.
Suzuki K; Muto Y; Fushihara K; Kanemoto K; Iida H; Sato E; Kikuchi C; Matsushima T; Kato E; Nomoto M; Yoshioka S; Ishii H
J Pharmacol Exp Ther; 2004 May; 309(2):607-15. PubMed ID: 14762098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
